News Incyte Corporation

Equities

INCY

US45337C1027

Real-time Estimate Cboe BZX Other stock markets 11:53:01 2024-05-09 am EDT			5-day change	1st Jan Change
53.23 ^USD	-0.52%		+0.28%	-15.21%

May. 07	Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	MT
May. 01	TD Cowen Adjusts Price Target on Incyte to $80 From $88	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	May. 07	MT
Incyte to Present at Upcoming Investor Conference	May. 02	BU
TD Cowen Adjusts Price Target on Incyte to $80 From $88	May. 01	MT
RBC Capital Adjusts Price Target on Incyte to $60 From $65	May. 01	MT
Piper Sandler Adjusts Price Target on Incyte to $80 From $85	May. 01	MT
Goldman Sachs Adjusts Price Target on Incyte to $60 From $63	May. 01	MT
Leerink Partners Adjusts Price Target on Incyte to $80 From $83, Keeps Outperform Rating	May. 01	MT
Citigroup Adjusts Price Target on Incyte to $80 From $81	May. 01	MT
BMO Capital Adjusts Incyte Price Target to $52 From $56	May. 01	MT
Truist Securities Trims Incyte's Price Target to $83 From $84, Buy Rating Maintained	Apr. 30	MT
Incyte's Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	Apr. 30	MT
Transcript : Incyte Corporation, Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Earnings Flash (INCY) INCYTE Posts Q1 Revenue $880.9M, vs. Street Est of $924.6M	Apr. 30	MT
Earnings Flash (INCY) INCYTE Posts Q1 EPS $0.64, vs. Street Est of $0.83	Apr. 30	MT
Incyte: Q1 Earnings Snapshot	Apr. 30	AQ
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs	Apr. 30	BU
Incyte Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Incyte Corporation Maintains Revenue Guidance for 2024	Apr. 30	CI
'Shadow Trading' Verdict A Reminder For Companies To Review Insider Trading Policies And Train Insiders	Apr. 29	AQ
SEC Secures Groundbreaking Win In Shadow Trading Insider Trading Case	Apr. 27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Incyte Corporation : Is a big change imminent?

October 26, 2023 at 10:00 am EDT